Drug-induced gingival enlargement: Series of cases

Authors

DOI:

https://doi.org/10.22267/rus.182001.113

Keywords:

Gingival overgrowth, Antihypertensive agents, Inmunosupressive agents, Anticonvulsants, Gingivectomy

Abstract

Introduction: Gingival enlargement (GA) is a benign condition of the oral cavity that is characterized by the excessive growth of the gingiva in mass and volume. This lesion is not only caused by hereditary factors or poor oral hygiene, but also by the intake of medications, including antihypertensive, anticonvulsant and immunosuppressive drugs. Objective: To sensitize the prevention or early care in patients with pathologies that merit the use of antihypertensive and anticonvulsants in conjunction with the dentist, to treat or avoid the drug-induced gingival enlargement (DIGE). Materials and methods: A series of clinical cases of patients with gingival enlargement by various drugs are reported, including Phenytoin, Amlodipine and Nifedipine. Periodontal and gingivectomy hygienic phase measures were applied to obtain better effects. Results: Satisfactory results were obtained with a considerable decrease in DIGE. Conclusions: The integral management is important in conjunction with the treating physician to follow up the drug that can be generating gingival enlargement. It is necessary to employ an initial approach with strategies of periodontal hygiene, and in severe cases and, as last resort, the periodontal surgery with gingivectomy and gingivoplasty.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Isabella Manzur-Villalobos, Universidad de Cartagena. Cartagena, Colombia

Odontóloga Universidad de Cartagena. Semillero de investigaciones grupo GITOUC Universidad de Cartagena.

Ivan Alejandro Díaz-Rengifo, Colegio Mayor Nuestra Señora del Rosario. Bogotá, Colombia

Médico y Cirujano Colegio Mayor Nuestra Señora del Rosario.

Daniella Manzur-Villalobos, Universidad de Cartagena. Cartagena, Colombia

Médica Universidad de Cartagena.

Antonio José Díaz-Caballero, Universidad de Cartagena. Cartagena, Colombia.

Odontólogo Universidad de Cartagena. Especialista en Periodoncia Universidad Javeriana, Magíster en Educación Universidad del Norte. Doctor en Ciencias Biomédicas Universidad de Cartagena. Profesor titular Facultad de Odontología Universidad de Cartagena.

References

Straka M, Varga I, Erdelský I, Straka-Trapezanlidis M, Krňoulová J. Drug-induced gingival enlargement. Neuroendocrinology Letters. 2014;35(7):567-76.

Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement. Journal of human hypertension. 2014;28(1):10-4.

Eroglu M, Uz O, Isilak Z, Tezcan M, Kilicaslan F, Yiginer O. Nifedipine-induced gingival hyperplasia: an overlooked adverse effect. J Clin Case Rep. 2012;2(225):1-2.

Andrew W, Evelyn W, Francis M, Mark J, Mark C. Pattern of Gingival Overgrowth among Patients on Antihypertensive Pharmacotherapy at a Nairobi Hospital in Kenya. Open Journal of Stomatology. 2014;4(4):169-173.

Gupta SJ, Madan R, Jhingran R. Drug Induced Gingival Overgrowth with Low-Dose Amlodipine: A Clinical Report. Asian Journal of Oral Health and Allied Sciences. 2013;3(2):81-86.

Mathur S, Khatri RK, Mathur R, Srivastava R, Nag B. Drug Induced Gingival Overgrowth: A Rare Case Report. Journal of clinical and diagnostic research: JCDR. 2015;9(1):ZD31-ZD33.

Wentz LA, Oliveira SC, Moreira CH, Rosing CK. Low prevalence of gingival overgrowth associated to new imunossupressive protocols with cyclosporin. Braz Oral Res. 2012;26(1):64-70.

Gurgel BCdV, Morais CRBd, Rocha-Neto PCd, Dantas EM, Pinto LP, Costa AdLL. Phenytoin-Induced Gingival Overgrowth Management with Periodontal Treatment. Brazilian dental journal. 2015;26(1):39-43.

Franco V, Perucca E. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects. Expert opinion on drug metabolism & toxicology. 2015;11(8):1269-79.

Calzado de Silva MdlC, Laurencio Rodríguez J, Peña Sisto M. Enfermedades causadas por fármacos en la cavidad bucal. Medisan. 2015;19(11):1386-98.

de Asúa DR, Suárez C. Diferencias y similitudes entre los bloqueadores de los receptores del calcio (antagonistas del calcio). Hipertension y riesgo vascular. 2013;30:20-9.

Lores CMQ, Quintero LG, Quintero LG, Quintero RSG, Orduñez YP. Efectividad de Amlodipino en el manejo de hipertensión arterial en población geriátrica. Revista Información Científica. 2015;90(2):209-18.

O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol. 1972;43(1):38.

Pedaballi P, Sundaram R, Ramachandran M. Prevalence of gingival enlargement secondary to calcium channel blockers in patients with cardiovascular diseases. J Indian Soc Periodontol. 2012;16(3):430-435.

Trackman P, Kantarci A. Molecular and clinical aspects of drug-induced gingival overgrowth. Journal of dental research. 2015;94(4):540-6.

Kim S, Jackson-Boeters L, Darling M, Rieder M, Hamilton D. Nifedipine induces periostin expression in gingival fibroblasts through TGF-beta. Journal of dental research. 2013;92(11):1022-8.

Mirabal YÁ, Carbonell LOM. Hiperplasia gingival inducida por amlodipino en paciente con periodontitis crónica. Presentación de un caso. MediCiego. 2016;23(1):36-42.

Batista ALA, de Mendonça AKP, de Almeida Freitas R, Alves PM, a Godoy GP, Nonaka CFW, et al. Immunohistochemical Analysis of Cell Proliferation and Bcl-2 Expression in Drug-Induced Gingival Overgrowth. Pesquisa Brasileira em Odontopediatria e Clinica Integrada. 2017;17(1):1-10.

Published

2018-01-01

How to Cite

1.
Manzur-Villalobos I, Díaz-Rengifo IA, Manzur-Villalobos D, Díaz-Caballero AJ. Drug-induced gingival enlargement: Series of cases. Univ. Salud [Internet]. 2018Jan.1 [cited 2024Nov.22];20(1):89-96. Available from: https://revistas.udenar.edu.co/index.php/usalud/article/view/3293

Issue

Section

Case report, or case study

Most read articles by the same author(s)